Arix Bioscience PLC
Tassos Konstantinou is an accomplished executive in the biotechnology and life sciences sectors, currently serving as Managing Director at SPRIM Global Investments since September 2024. Previously, Konstantinou held the position of Managing Director at Arix Bioscience plc and has been involved as a board member for several companies, including Ensoma, Artios, Evommune, Sorriso Pharmaceuticals, Kynos Therapeutics Ltd., and Oxular. With a strong background in investment management as a Life Sciences Investor at IP Group plc, Konstantinou's academic foundation includes a Ph.D. in Molecular Oncology from the University of Oxford and a Bachelor of Science in Biology from Aristotle University of Thessaloniki.
This person is not in any teams
Arix Bioscience PLC
Arix Bioscience plc is a United Kingdom-based healthcare and life science company. The Company is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. Its principal activity is to source, finance and develop healthcare and life science businesses across the world. The Company focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company holds interests in BioMotiv, OptiKira LLC, Autolus, Depixus SAS, Verona Pharma plc and Artios Pharma Ltd. The Company has agreements with universities in the United Kingdom, Europe and Australia, providing direct access to new technologies. It also has access to a range of research projects from the United States academic institutions. Its subsidiaries include Arix Bioscience Holdings Limited, Arix US Inc and Arthurian Life Sciences GP Limited.